96 related articles for article (PubMed ID: 18506170)
1. Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
de Francisco AL; Piñera C; Palomar R
Nat Clin Pract Nephrol; 2008 Jul; 4(7):366-7. PubMed ID: 18506170
[No Abstract] [Full Text] [Related]
2. Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
Coyne DW
Nat Clin Pract Nephrol; 2008 Jul; 4(7):364-5. PubMed ID: 18477990
[No Abstract] [Full Text] [Related]
3. Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism.
Dorsch O
Nephrol Dial Transplant; 2007 Feb; 22(2):637-40. PubMed ID: 17095580
[No Abstract] [Full Text] [Related]
4. The role of cinacalcet in treating secondary hyperparathyroidism.
Brommage D; Gallgano C
Nephrol Nurs J; 2005; 32(2):229-31. PubMed ID: 15889812
[TBL] [Abstract][Full Text] [Related]
5. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
Drüeke TB
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
Iseki K
Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
[TBL] [Abstract][Full Text] [Related]
7. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
8. Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?
Fukagawa M
Nat Clin Pract Nephrol; 2006 May; 2(5):248-9. PubMed ID: 16932435
[No Abstract] [Full Text] [Related]
9. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
Dong BJ
Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
[TBL] [Abstract][Full Text] [Related]
10. New approaches to treatment of secondary hyperparathyroidism.
Locatelli F; Limardo M; Pontoriero G
Curr Opin Investig Drugs; 2008 Apr; 9(4):363-70. PubMed ID: 18393103
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of cinacalcet in addition to standard of care in the UK.
Ray JA; Valentine WJ; Palmer AJ
Nephrol Dial Transplant; 2007 Nov; 22(11):3355-7; author reply 3357-8. PubMed ID: 17785347
[No Abstract] [Full Text] [Related]
12. Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
Kalantar-Zadeh K; Kovesdy CP
Am J Kidney Dis; 2009 Feb; 53(2):183-8. PubMed ID: 19166796
[No Abstract] [Full Text] [Related]
13. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
[TBL] [Abstract][Full Text] [Related]
14. Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?
Kakuta T; Tanaka R; Kanai G; Sawaya A; Hirukawa T; Sato A; Saito A
Ther Apher Dial; 2009 Oct; 13 Suppl 1():S20-7. PubMed ID: 19765255
[TBL] [Abstract][Full Text] [Related]
15. Use of cinacalcet HCl to achieve the recommended targets of bone metabolism in a patient with therapy-resistant renal hyperparathyroidism.
Bahner U; Brandl M; Nies C; Schmidt-Gayk H
J Ren Nutr; 2008 Jul; 18(4):383-8. PubMed ID: 18558304
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet improves control of secondary hyperparathyroidism in peritoneal dialysis: a multicenter study.
Portolés J; López-Sánchez P; Bajo MA; Castellano I; del Peso G; Rodríguez JR; Ribera M; Ortigosa A; Selgas R
Perit Dial Int; 2012; 32(2):208-11. PubMed ID: 22383721
[No Abstract] [Full Text] [Related]
17. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA
Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
[TBL] [Abstract][Full Text] [Related]
19. Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism.
Jean G; Chazot C; Charra B
Nephrol Dial Transplant; 2007 Jul; 22(7):2102-3. PubMed ID: 17395648
[No Abstract] [Full Text] [Related]
20. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism.
Koizumi M; Komaba H; Nakanishi S; Fujimori A; Fukagawa M
Nephrol Dial Transplant; 2012 Feb; 27(2):784-90. PubMed ID: 21730210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
